Pharma Research Products Co. Ltd. | Mutual Funds
Mutual Funds that own Pharma Research Products Co. Ltd.
DFA Emerging Markets Small Cap Series
41,159
0.44%
0
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
17,341
0.18%
3,835
0%
04/30/2018
Mirae Asset TIGER Health Care ETF
8,376
0.09%
2,190
0.22%
04/30/2018
MainStay VP Emerging Markets Equity Portfolio.
4,123
0.04%
4,123
0.03%
05/31/2018
iShares III Plc - MSCI Emerging Markets Small Cap
2,542
0.03%
0
0.02%
09/05/2018
CREF Stock Account
2,394
0.03%
0
0%
03/31/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
1,327
0.01%
0
0%
12/31/2017
DFA Emerging Markets Social Core Equity Portfolio
787
0.01%
0
0%
04/30/2018
Old Westbury Small & Mid Cap Fund
765
0.01%
0
0%
04/30/2018
John Hancock II - Emerging Markets Fund
612
0.01%
0
0%
04/30/2018
| Address |
77-19 Gwahakdanji-ro
Gangneung GA 25452
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.pr-products.co.kr |
| Updated |
09/14/2018 |
| Pharma Research Products Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. It offers products which fall under the categories of QOL (Quality of Life) and tissue regeneration. In addition, it also engages in the manufacture of medical equipment. |
